EXANE DERIVATIVES - MEDIFAST INC ownership

MEDIFAST INC's ticker is MED and the CUSIP is 58470H101. A total of 266 filers reported holding MEDIFAST INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of MEDIFAST INC
ValueSharesWeighting
Q2 2022$361,000
-99.6%
2
-99.6%
0.00%
-100.0%
Q1 2022$89,483,000
-32.3%
524
-17.0%
0.02%
-21.9%
Q4 2021$132,146,000
-15.9%
631
-22.7%
0.03%
-15.8%
Q3 2021$157,189,000
-40.2%
816
-14.2%
0.04%
-36.7%
Q2 2021$263,012,000
-0.0%
951
-23.4%
0.06%
-20.0%
Q1 2021$263,069,000
-24.9%
1,242
-30.4%
0.08%
-27.2%
Q4 2020$350,451,0001,7850.10%
Other shareholders
MEDIFAST INC shareholders Q4 2020
NameSharesValueWeighting ↓
Engaged Capital LLC 611,609$20,519,00016.75%
GOLDEN GATE PRIVATE EQUITY, INC. 472,205$15,842,0004.83%
COOPER CREEK PARTNERS MANAGEMENT LLC 116,966$3,924,0004.13%
TigerShark Management, LLC 50,000$1,678,0001.70%
Pacific Ridge Capital Partners, LLC 96,226$3,228,0001.37%
12 West Capital Management LP 306,830$10,294,0001.28%
Cambria Investment Management, L.P. 80,653$2,706,0000.97%
Visium Asset Management, LP 1,350,000$45,293,0000.64%
SMITH, MOORE & CO. 31,897$1,070,0000.57%
Matarin Capital Management, LLC 30,870$1,035,689,0000.45%
View complete list of MEDIFAST INC shareholders